A Comparision of the Results of Rat and Mouse Carcinogenicity Studies Conducted on Pharmaceuticals
スポンサーリンク
概要
- 論文の詳細を見る
- 日本トキシコロジー学会の論文
- 1998-10-07
著者
-
Sato Motonobu
Japan Pharmaceutical Manufacturers Association (jpma)
-
YASUBA MASASHI
Japan Pharmaceutical Manufacturers Association
-
AOKI Toyohiko
Drug Safety Research Laboratories, Eisai Co., Ltd.
-
Mutai Mamoru
Japan Pharmaceutical Manufacturers Association (jpma)
-
Aoki Toyohiko
Drug Safety Research Laboratories Eisai Co. Ltd.)
-
Irimura Kenji
Japan Pharmaceutical Manufacturers Association (jpma)
-
Usui Toshimi
Japan Pharmaceutical Manufacturers Association (jpma)
-
MATSUZAWA TOSHIAKI
Japan Pharmaceutical Manufacturers Association
-
KOGA Teruji
Japan Pharmaceutical Manufacturers Association (JPMA), Tokyo, Japan
-
NAGAYAMA Satoshi
Japan Pharmaceutical Manufacturers Association (JPMA), Tokyo, Japan
-
FUJII Toshiyuki
Japan Pharmaceutical Manufacturers Association (JPMA), Tokyo, Japan
-
YAMASHITA Satoru
Japan Pharmaceutical Manufacturers Association (JPMA), Tokyo, Japan
-
Koga Teruji
Japan Pharmaceutical Manufacturers Association (jpma)
-
Fujii Toshiyuki
Japan Pharmaceutical Manufacturers Association (jpma)
-
Nagayama Satoshi
Japan Pharmaceutical Manufacturers Association (jpma)
-
Yasuba Masashi
Japan Pharmaceutical Manufacturers Association (jpma)
-
Matsuzawa Toshiaki
Japan Pharmaceutical Manufacturers Association (jpma)
-
Aoki Toyohiko
Drug Safety Japan Global Drug Safety Biopharmaceutical Assessments Core Function Unit
-
Yamashita Satoru
Japan Pharmaceutical Manufacturers Association (jpma)
関連論文
- Practical use of ICH guidelines for special toxicology studies : Questionnaire survey by JPMA.(GENERAL SESSION BY ORAL PRESENTATION)(GENOTOXICITY)
- Current Status of Carcinogenicity Assessment of Peroxisome Proliferator-Activated Receptor Agonists by the US FDA and a Mode-of-Action Approach to the Carcinogenic Potential
- Proteomic analysis for neuronal vacuolation induced by MK-801 in rat retrosplenial cortex
- Questionnaire survey of application in S7A Safety Pharmacology Guideline (Part 2) : Point of GLP (STATISTICAL METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Questionnaire survey of application in S7A Safety Pharmacology Guideline (Part 1) : Point of experimental items (STATISTICAL METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Survey of Carcinogenicity Studies of the Pharmaceuticals in Rodents
- A Comparision of the Results of Rat and Mouse Carcinogenicity Studies Conducted on Pharmaceuticals
- Questionnaire survey on cardiac electrophysiology examination in safety pharmacology studies.(GENERAL SESSION BY POSTER PRESENTATION)(SAFETY PHARMACOLOGY)
- Survey of pharmacology study conduct using outside sources in pharmaceutical companies in Japan.(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STUDY(CURRENT SURVEY))
- Study Monitor : The Surveillance of Outsourced Non-Clinical Studies : Draft Report, Final Report, Archives, and Quality Assurance(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STUDY(CUR
- Study monitor : the Surveillance of Outsourced Non-Clinical Studies (Reproductive Studies,Pathology and Toxicokinetics).(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STUDY(CURRENT SURV
- Study Monitor. The Surveillance of Outsourced Non-Clinical Studies : Testing facility checking, Protocol, Formulation and In-life phase(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STU
- Study Monitor. Introduction of the Surveillance for Outsourcing Non-Clinical Studies and Summary of Toxicology.(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STUDY(CURRENT SURVEY))
- P6-44 The effects of chronic dietary restriction on biological characteristics in Crj:CD(SD)IGS rats(DRUG METABOLISM/CARCINOGENICITY)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)
- Collaborative work on evaluation of ovarian toxicity : 11) Two- or four-week repeated-dose studies and fertility study of ethylene glycol monomethyl ether in female rats
- Summary of Questionnaire Surveys of Toxicokinetics in Pharmaceutical Industries in Japan.(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : STRATEGIC TOXICOKINETICS ON DRUG DISCOVERY(CURRENT SURVEY))
- Mechanism for benzothiazole derivative-induced hepatotoxicity in rats(SYMPOSIUM 1 : MECHANISMS OF HEPATOTOXIC EFFECTS)
- TOXICOLOGICAL RESPONSE OF RATS TO A NOVEL MONOAMINE OXIDASE TYPE-A INHIBITOR, (5R)-3-[2-((1S)-3-CYANO-1-HYDROX-YPROPYL)BENZOTHIAZOL-6-YL]-5-METHOXYMETHYL-2-OXAZOLIDI-NONE (E2011), ORALLY ADMINISTERED FOR 13 WEEKS
- Responsibility of Monitor for Quality Assurance of Outsourcing Non-clinical Studies.(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STUDY(CURRENT SURVEY))
- Report 4 : CASE STUDY OF CARCINOGENICITY BY INITIATION-PROMOTION MODEL (CARCINOGENlClTY STUDIES)
- P11-13 Questionnaire Survey of Functional Observational Battery in Domestic and Foreign Non-clinical Contract Research Organization.
- O10-18 Questionnaire Survey of Functional Observational Battery in Domestic and Foreign Non-clinical Contract Research Organization.
- Practical use of ICH guidelines for carcinogenicity studies : Questionnaire survey by JPMA.(GENERAL SESSION BY POSTER PRESENTATION)(CARCINOGENICITY)
- Proteomic analysis for neuronal vacuolation induced by MK-801 in rat retrosplenial cortex
- ^1H-NMR Based Metabonomics Study of Galactosamine, Methylene Dianiline, and Clofibrate in Rats(Liver, Alimentary system, Proceedings of the 32nd Annual Meeting)
- P6-57 NMR spectroscopic analysis of rat urine samples after D-galactosamine or 4-aminophenol administration(TOXICOGENOMICS)(GENERAL SESSION BY POSTER PRESENTATION)(Proceedings of the 31st Annual Meeting)